NYSE : WWW
Wolverine World Wide, Inc. — Key statistics
Consumer Discretionary · Footwear & Accessories · United States
Last price 20.9 USD (Oct 30, 2026, 9:46 AM EDT) · Market cap 1.72B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.76B |
| Enterprise Value | 2.34B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | Oct 1, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 82.07M |
| Shares Outstanding | 82.07M |
| Shares Change (YoY) | +2.11% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 1.47% |
| Owned by Institutions (%) | 100.19% |
| Float | 75.93M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 16.74 |
| Forward PE | 12.11 |
| PS Ratio | 0.90 |
| Forward PS | 0.85 |
| PB Ratio | 3.80 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 10.07 |
| P/OCF Ratio | 9.65 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 22.25 |
| EV / Sales | 1.20 |
| EV / EBITDA | 11.87 |
| EV / EBIT | 13.50 |
| EV / FCF | 13.43 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.55 |
| Quick Ratio | 0.80 |
| Debt / Equity | 1.59 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | 4.26 |
| Interest Coverage | 5.82 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 27.65% |
| Return on Assets (ROA) | 6.19% |
| Return on Invested Capital (ROIC) | 13.01% |
| Return on Capital Employed (ROCE) | 14.14% |
| Weighted Average Cost of Capital (WACC) | 10.51% |
| Revenue Per Employee | $639,934 |
| Profits Per Employee | $34,623 |
| Employee Count | 3,050 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 3.53 |
Taxes
| Measure | Value |
|---|
| Income Tax | 27.70M |
| Effective Tax Rate | 19.53% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.70 |
| 52-Week Price Change | -5.73% |
| 50-Day Moving Average | 19.67 |
| 200-Day Moving Average | 18.10 |
| Relative Strength Index (RSI) | 64.27 |
| Average Volume (20 Days) | 951,425 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.77M |
| Short Previous Month | 5.93M |
| Short % of Shares Out | 7.03% |
| Short % of Float | 7.60% |
| Short Ratio (days to cover) | 6.80 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.95B |
| Gross Profit | 919.70M |
| Operating Income | 174.10M |
| Pretax Income | 141.80M |
| Net Income | 105.60M |
| EBITDA | 198.00M |
| EBIT | 174.10M |
| Earnings Per Share (EPS) | $1.28 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 158.50M |
| Total Debt | 745.40M |
| Net Cash | -586.90M |
| Net Cash Per Share | -$7.15 |
| Equity (Book Value) | 468.40M |
| Book Value Per Share | 5.47 |
| Working Capital | 261.00M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 182.60M |
| Capital Expenditures | -7.60M |
| Depreciation & Amortization | 23.90M |
| Net Borrowing | -108.50M |
| Free Cash Flow | 175.00M |
| FCF Per Share | $2.13 |
Margins
| Measure | Value |
|---|
| Gross Margin | 47.12% |
| Operating Margin | 8.92% |
| Pretax Margin | 7.27% |
| Profit Margin | 5.55% |
| EBITDA Margin | 10.14% |
| EBIT Margin | 8.92% |
| FCF Margin | 8.97% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.40 |
| Dividend Yield | 1.87% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 31.29% |
| FCF Payout Ratio | 18.76% |
| Buyback Yield | -2.11% |
| Shareholder Yield | -0.25% |
| Earnings Yield | 5.97% |
| FCF Yield | 9.93% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $24.30 |
| Price Target Difference | 13.55% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 5.95% |
| EPS Growth Forecast (3Y) | 16.64% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 4, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.25 |
| Piotroski F-Score | 8 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |